Log In

Part Description

LP220476-8   Cetuximab
Cetuximab is a monoclonal antibody used to treat advanced squamous cell carcinoma of the head and neck (SCCHN) and metastatic colorectal cancer (mCRC). Cetuximab competes to bind to the epidermal growth factor receptor (EGRF) and then subsequently inhibits tumor growth and metastasis. Cetuximab is used in conjunction with radiation in the treatment of SCCHN. It is also used as the sole therapy for SCCHN in instances of recurrent or metastatic disease where platinum-based therapy was not effective. In patients with mCRC cetuximab is used in combination with irinotecan or by itself in patients who are unable to tolerate irinotecan. PMID: 18034592 Some patients develop treatment-related hypersensitivity to
cetuximab and detection of anti-cetuximab IgE may help physicians identify patients at risk of a severe infusion reaction. PMID: 25471028 Source: Regenstrief LOINC

LOINC Names Get Info

Fully-Specified Name
Cetuximab Ab.IgE:ACnc:Pt:Ser:Qn:
Long Common Name
Cetuximab IgE Ab [Units/volume] in Serum
Short Name
Cetuximab IgE Qn
Display Name
Cetuximab IgE Qn (S)
Consumer Name Alpha Get Info
Cetuximab allergy test

Part Model Get Info

  • Component
    Cetuximab Ab.IgE
    LP220406-5
    • Analyte
      Cetuximab Ab.IgE
      LP220406-5
      • Component Numerator
        Cetuximab Ab.IgE
        LP220406-5
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    ACnc
    LP6773-8
  • Time
    Pt
    LP6960-1
  • System
    Ser
    LP7567-3
    • System Core
      Ser
      LP7567-3
    • Super System
      NULL
       
  • Scale
    Qn
    LP7753-9
  • Method
    NULL
     

Basic Attributes

Class
ALLERGY
Type
Laboratory
First Released
Version 2.58
Last Updated
Version 2.58 (ADD)
Order vs. Observation
Both

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)Cetuximab IgE:Arbitrární koncentrace:Časový bod:Sérum:Kvantitativní:
el-GRGreek (Greece)Κετουξιμάμπη Ab.IgE:ACnc:Pt:Ορός:Qn:
Synonyms: Ab.IgE ACnc ALLERGY Pt Qn Ανοσοσφαιρίνη E Αντίσωμα Κετουξιμάμπη Ορός
es-ESSpanish (Spain)Cetuximab IgE:Concentración arbitraria:Punto temporal:Suero:Qn:
Synonyms: Cuantitativo
es-MXSpanish (Mexico)Cetuximab Ab.IgE:Concentración arbitraria:Punto temporal:Suero:Cuantitativo:
fr-FRFrench (France)Cetuximab Ac IgE:Arbitraire/Volume:Ponctuel:Sérum:Numérique:
it-ITItalian (Italy)Cetuximab Ab.IgE:ACnc:Pt:Siero:Qn:
Synonyms: anticorpi anti-IgE anticorpo Concentrazione Arbitraria Punto nel tempo (episodio) Risposta agli antigeni Siero
nl-NLDutch (Netherlands)cetuximab As.IgE:eenheid/volume:moment:serum:kwantitatief:
Synonyms: antistof; antilichaam
zh-CNChinese (China)西妥昔单抗 抗体.IgE:任意型浓度:时间点:血清:定量型:
Synonyms: Ab.IgE;IgE;抗体 IgE Ab;自身抗体 任意型浓度(单位体积);任意浓度;单位体积的任意单位数;人工型浓度 免疫球蛋白 E 可用数量表示的;定量性;数值型;数量型;连续数值型标尺 时刻;随机;随意;瞬间 西妥昔单克隆抗体;Cetuximab 单抗;西妥昔

Example Units

UnitSource
k[IU]/mLExample UCUM Units

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=82541-4